☰

Nader H. Moniri, Ph.D. - Publications

Affiliations: 
2004 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmaceutical Chemistry, Pharmacology, Biochemistry
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Singh K, Teyani RL, Moniri NH. Agonists and hydrogen peroxide mediate hyperoxidation of β2-adrenergic receptor in airway epithelial cells: Implications for tachyphylaxis to β2-agonists in constrictive airway disorders. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 168: 115763. PMID 37865997 DOI: 10.1016/j.biopha.2023.115763  0.734
2023 Teyani R, Moniri NH. Gut feelings in the islets: the role of the gut microbiome and the SCFA receptors FFA2/FFA3 on β-cell function and metabolic regulation. British Journal of Pharmacology. PMID 37620991 DOI: 10.1111/bph.16225  0.406
2023 Menon SN, Zerin F, Ezewudo E, Simon NP, Menon SN, Daniel ML, Green AJ, Pandey A, Mackay CE, Hafez S, Moniri NH, Hasan R. Neflamapimod inhibits endothelial cell activation, adhesion molecule expression, leukocyte attachment and vascular inflammation by inhibiting p38 MAPKα and NF-κB signaling. Biochemical Pharmacology. 115683. PMID 37429422 DOI: 10.1016/j.bcp.2023.115683  0.646
2023 Karmokar PF, Moniri NH. Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT. Cancer Cell International. 23: 126. PMID 37355607 DOI: 10.1186/s12935-023-02967-x  0.812
2023 Karmokar PF, Moniri NH. Free-Fatty Acid Receptor-4 (FFA4/GPR120) differentially regulates migration, invasion, proliferation and tumor growth of papillary renal cell carcinoma cells. Biochemical Pharmacology. 115590. PMID 37201877 DOI: 10.1016/j.bcp.2023.115590  0.8
2022 Karmokar PF, Moniri NH. Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells. Biochemical Pharmacology. 206: 115328. PMID 36309079 DOI: 10.1016/j.bcp.2022.115328  0.809
2022 Singh K, Senatorov IS, Cheshmehkani A, Karmokar PF, Moniri NH. The Skeletal Muscle Relaxer Cyclobenzaprine Is a Potent Non-Competitive Antagonist of Histamine H1 Receptors. The Journal of Pharmacology and Experimental Therapeutics. 380: 202-209. PMID 34992159 DOI: 10.1124/jpet.121.000998  0.716
2021 Moniri NH, Farah Q. Short-chain free-fatty acid G protein-coupled receptors in colon cancer. Biochemical Pharmacology. 114483. PMID 33631190 DOI: 10.1016/j.bcp.2021.114483  0.35
2020 Senatorov IS, Cheshmehkani A, Burns RN, Singh K, Moniri NH. Carboxy-terminal phosphoregulation of the long splice isoform of Free-Fatty Acid Receptor-4 mediates β-arrestin recruitment and signaling to ERK1/2. Molecular Pharmacology. PMID 32132133 DOI: 10.1124/Mol.119.117697  0.781
2020 Rambacher KM, Moniri NH. Cysteine redox state regulates human β2-adrenergic receptor binding and function. Scientific Reports. 10: 2934. PMID 32076070 DOI: 10.1038/S41598-020-59983-4  0.805
2020 Chitre NM, Wood BJ, Ray A, Moniri NH, Murnane KS. Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum. Neuropharmacology. 107976. PMID 32001239 DOI: 10.1016/J.Neuropharm.2020.107976  0.323
2019 Chitre NM, Moniri NH, Murnane KS. Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders. Cns & Neurological Disorders Drug Targets. PMID 31724519 DOI: 10.2174/1871527318666191114093749  0.419
2019 Rambacher KM, Moniri NH. The β2-adrenergic receptor-ROS signaling axis: an overlooked component of β2AR function? Biochemical Pharmacology. 113690. PMID 31697929 DOI: 10.1016/J.Bcp.2019.113690  0.795
2019 Murnane KS, Guner OF, Bowen JP, Rambacher KM, Moniri NH, Murphy TJ, Daphney CM, Oppong-Damoah A, Rice KC. The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo. Pharmacology, Biochemistry, and Behavior. PMID 30998954 DOI: 10.1016/J.Pbb.2019.04.003  0.775
2019 Rambacher KM, Moniri NH. Redox Deficient Cysteine Residues Impair β2‐Adrenergic Receptor Function The Faseb Journal. 33. DOI: 10.1096/Fasebj.2019.33.1_Supplement.668.3  0.432
2018 Senatorov IS, Moniri NH. The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines. Biochemical Pharmacology. PMID 29452095 DOI: 10.1016/J.Bcp.2018.02.011  0.819
2017 Cheshmehkani A, Senatorov IS, Dhuguru J, Ghoneim O, Moniri NH. Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal β-arrestin phosphosensor in Raw 264.7 macrophages. Biochemical Pharmacology. PMID 28943238 DOI: 10.1016/J.Bcp.2017.09.008  0.77
2016 Moniri NH. Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders. Biochemical Pharmacology. PMID 26827942 DOI: 10.1016/J.Bcp.2016.01.021  0.542
2015 Cheshmehkani A, Senatorov IS, Kandi P, Singh M, Britt A, Hayslett R, Moniri NH. Fish oil and flax seed oil supplemented diets increase FFAR4 expression in the rat colon. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 64: 809-15. PMID 26275932 DOI: 10.1007/S00011-015-0864-3  0.718
2014 Burns RN, Singh M, Senatorov IS, Moniri NH. Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail. Biochemical Pharmacology. 87: 650-9. PMID 24412271 DOI: 10.1016/J.Bcp.2013.12.016  0.791
2012 Singh M, Moniri NH. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2. Biochemical Pharmacology. 84: 661-9. PMID 22728070 DOI: 10.1016/J.Bcp.2012.06.012  0.813
2011 Burns RN, Moniri NH. Agonist- and hydrogen peroxide-mediated oxidation of the β2 adrenergic receptor: evidence of receptor s-sulfenation as detected by a modified biotin-switch assay. The Journal of Pharmacology and Experimental Therapeutics. 339: 914-21. PMID 21917560 DOI: 10.1124/Jpet.111.185975  0.81
2010 Burns RN, Moniri NH. Agonism with the omega-3 fatty acids alpha-linolenic acid and docosahexaenoic acid mediates phosphorylation of both the short and long isoforms of the human GPR120 receptor. Biochemical and Biophysical Research Communications. 396: 1030-5. PMID 20471368 DOI: 10.1016/J.Bbrc.2010.05.057  0.815
2007 Booth RG, Moniri NH. Novel ligands stabilize stereo-selective conformations of the histamine H1 receptor to activate catecholamine synthesis. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 56: S43-4. PMID 17806174 DOI: 10.1007/S00011-006-0521-Y  0.668
2007 Moniri NH, Daaka Y. Agonist-stimulated reactive oxygen species formation regulates beta2-adrenergic receptor signal transduction. Biochemical Pharmacology. 74: 64-73. PMID 17451656 DOI: 10.1016/J.Bcp.2007.03.016  0.485
2006 Moniri NH, Booth RG. Role of PKA and PKC in histamine H1 receptor-mediated activation of catecholamine neurotransmitter synthesis. Neuroscience Letters. 407: 249-53. PMID 16978782 DOI: 10.1016/J.Neulet.2006.08.051  0.676
2006 Guo R, Kasbohm EA, Arora P, Sample CJ, Baban B, Sud N, Sivashanmugam P, Moniri NH, Daaka Y. Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells. Endocrinology. 147: 4883-92. PMID 16809448 DOI: 10.1210/En.2005-1635  0.411
2006 Wang G, Moniri NH, Ozawa K, Stamler JS, Daaka Y. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proceedings of the National Academy of Sciences of the United States of America. 103: 1295-300. PMID 16432212 DOI: 10.1073/Pnas.0508354103  0.399
2005 Booth RG, Moniri NH. Ligand-directed multifunctional signaling of histamine H1 receptors. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 54: S44-5. PMID 15928829 DOI: 10.1007/S00011-004-0420-Z  0.69
2004 Moniri NH, Covington-Strachan D, Booth RG. Ligand-directed functional heterogeneity of histamine H1 receptors: novel dual-function ligands selectively activate and block H1-mediated phospholipase C and adenylyl cyclase signaling. The Journal of Pharmacology and Experimental Therapeutics. 311: 274-81. PMID 15169829 DOI: 10.1124/Jpet.104.070086  0.695
2004 Moniri NH, Booth RG. Functional heterogeneity of histamine H(1) receptors. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 53: S71-2. PMID 15054625 DOI: 10.1007/S00011-003-0334-1  0.683
2002 Booth RG, Moniri NH, Bakker RA, Choksi NY, Nix WB, Timmerman H, Leurs R. A novel phenylaminotetralin radioligand reveals a subpopulation of histamine H(1) receptors. The Journal of Pharmacology and Experimental Therapeutics. 302: 328-36. PMID 12065734 DOI: 10.1124/Jpet.302.1.328  0.655
Show low-probability matches.